Thema: US10806X1028
BBIO, US10806X1028
usa-3004860_1920.jpg - Foto: THN
BridgeBio Pharma stock nears key BBP-418 FDA decision
BridgeBio Pharma stock is heading toward a November 27 FDA decision for BBP-418. Third-quarter revenue rose to USD 353.2 million.
ad-hoc-news.de, vor 23 Minuten
BBIO, US10806X1028
Citigroup cuts target for BridgeBio Pharma stock to USD ...
Analysts average USD 104.90 across 24 firms with a Moderate Buy rating on October 19, 2026. BBIO stock costs EUR 60.12 on October 20, 2026.
ad-hoc-news.de, 20.10.26 20:33 Uhr
BBIO, US10806X1028
BridgeBio Pharma stock stood 26.9 percent below its 52-week ...
Market value was USD 13.0 billion on October 16, 2026. BridgeBio Pharma stock last stood at EUR 58.98 on gettex on October 16, 2026, below EUR 80.73.
ad-hoc-news.de, 17.10.26 21:13 Uhr
BBIO, US10806X1028
UBS sets USD 92.00 target for BridgeBio Pharma stock
Q2 revenue reached USD 243.68 million on August 10, 2026. BridgeBio Pharma stock costs EUR 59.91 on October 15, 2026 at 6:44 p.m. CEST.
ad-hoc-news.de, 15.10.26 18:55 Uhr
BBIO, US10806X1028
BridgeBio Pharma stock heads into new acoramidis data
BridgeBio Pharma stock was at USD 66.73 on October 7, 2026, as HFSA prepares new acoramidis data. Q2 revenue rose 120.4 percent to USD 243.68 million.
ad-hoc-news.de, 08.10.26 02:57 Uhr
BBIO, US10806X1028
BridgeBio Pharma stock presents new cardiac data for BBP-418 ...
BridgeBio Pharma stock was trading at USD 66.54 on October 5, 2026, down 1.06 percent on Nasdaq. Q2 revenue reached USD 243.7 million.
ad-hoc-news.de, 05.10.26 19:15 Uhr
BBIO, US10806X1028
BridgeBio Pharma stock finds support near USD 66
BridgeBio Pharma stock traded at USD 66.85 on September 22, 2026, below its USD 90.17 yearly high. Revenue reached USD 502.08 million in fiscal 2025.
ad-hoc-news.de, 23.09.26 07:40 Uhr
BBIO, US10806X1028
BridgeBio Pharma stock gains support as HC Wainwright trims ...
